Baldwin Wealth Partners’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-33
Closed -$8K 808
2022
Q3
$8K Hold
33
﹤0.01% 534
2022
Q2
$7K Hold
33
﹤0.01% 572
2022
Q1
$23K Hold
33
﹤0.01% 467
2021
Q4
$23K Hold
33
﹤0.01% 442
2021
Q3
$25K Hold
33
﹤0.01% 430
2021
Q2
$25K Hold
33
﹤0.01% 446
2021
Q1
$27K Buy
+33
New +$25.5K ﹤0.01% 423

Other funds holding OM

Baldwin Wealth Partners's OM Position: Q4 2022 in Review

Baldwin Wealth Partners sold out of Outset Medical (OM) in Q4 2022, closing a stake of 33 shares — an estimated $8K sold.

Baldwin Wealth Partners first reported a position in OM in Q1 2021 and held it in 7 quarters. The position peaked at $27K in Q1 2021. 152 funds tracked by Wall St. Rank hold OM as of Q4 2022.

  • Baldwin Wealth Partners reported no remaining Outset Medical position as of Q4 2022 after selling out during the quarter.
  • Baldwin Wealth Partners sold 33 Outset Medical shares in Q4 2022, an estimated $8K.
  • Baldwin Wealth Partners first reported a position in Outset Medical in Q1 2021 and held it in 7 quarters.
  • Baldwin Wealth Partners's Outset Medical position peaked at $27K in Q1 2021.
  • 152 funds tracked by Wall St. Rank held Outset Medical as of Q4 2022.

Based on Baldwin Wealth Partners's 13F filing for Q4 2022, filed 27 Jan 2023.